Tag: cell and gene therapy market trends

Uncover key drivers, emerging technologies, and competitive movements shaping the cell and gene therapy clinical trial services market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Cell And Gene Therapy Clinical Trial Services Market show for the 2026–2030 period?

The size of the cell and gene therapy clinical trial services market has expanded significantly in recent years. This market is projected to expand from $4.18 billion in 2025 to $4.62 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. Historically, this growth is a result of an increasing number of cell and gene therapy clinical trials, a rise in outsourcing to specialized cros, the growing complexity of trial designs, the expansion of rare disease research, and stricter regulatory oversight for advanced therapies.

The cell and gene therapy clinical trial services market is projected to experience robust expansion over the coming years, reaching a valuation of $6.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. This anticipated growth throughout the forecast period stems from factors such as a heightened demand for late-stage clinical trial services, the increasing uptake of digital trial technologies, the broader implementation of global patient recruitment initiatives, an intensified focus on incorporating real-world evidence, and greater financial commitments to precision clinical research. Key developments expected during the forecast timeframe encompass a rising embrace of decentralized clinical trial models, the expanded utilization of digital platforms for patient recruitment, the progressive integration of sophisticated data management systems, the broadening of global trial site networks, and a heightened emphasis on adhering to regulatory standards and ensuring trial accuracy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

What Drivers Are Shaping The Development Of The Cell And Gene Therapy Clinical Trial Services Market?

The increasing occurrence of genetic disorders is anticipated to fuel the expansion of the cell and gene therapy clinical trial services market in the future. These conditions stem from alterations in an individual’s DNA or genetic makeup. Several factors contribute to the growing frequency of genetic diseases, such as enhanced access to genetic testing, the emergence of genetic mutations, and the commonness of marriages between relatives. Cell and gene therapy clinical trial services tackle the increasing prevalence of genetic diseases by fostering new treatment development, customizing therapies for specific patients, speeding up the application of research in clinical settings, and broadening the choices for individuals affected by genetic disorders. For example, in 2023, data from the National Health Service, a UK government body, indicated that sickle cell disorder (SCD) is England’s most common genetic condition, affecting approximately 17,000 individuals (NHSE, 2023). Consequently, the growing incidence of genetic diseases is a key factor boosting the cell and gene therapy clinical trial services market’s growth.

Which Segments Are Contributing To The Growth Of The Cell And Gene Therapy Clinical Trial Services Market?

The cell and gene therapy clinical trial services market covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services

2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy

3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection

How Are New Market Trends Shaping The Landscape Of The Cell And Gene Therapy Clinical Trial Services Market?

Major companies operating in the cell and gene therapy clinical trial services market are concentrating their efforts on integrating advanced technology, particularly customer relationship management systems, to boost efficiency and gain a competitive advantage. The customer relationship management system utilized by cell and gene therapy clinical trial services streamlines and coordinates interactions with trial participants, healthcare providers, and other stakeholders throughout the clinical trial process. For instance, in April 2023, AmerisourceBergen Corporation, a US-based healthcare company, launched the Cell and Gene Therapy (CGT) Integration Hub, a platform intended to increase connectivity and streamline processes across the cell and gene therapy treatment pathway. This platform is supported by AmerisourceBergen’s customer relationship management (CRM) system and aims to simplify the path-to-care process, partly by providing physicians and patient services teams with improved visibility across the therapy development and delivery process. The CGT Integration Hub, which incorporates features such as expedited benefits investigation, real-time status tracking, and proactive alerts, seeks to simplify care coordination, minimize barriers, and enhance the overall patient and provider experience when delivering cell and gene therapies.

Who Are The Major Companies Operating In The Cell And Gene Therapy Clinical Trial Services Market?

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Cell And Gene Therapy Clinical Trial Services Market?

North America was the largest region in the cell and gene therapy clinical trial services market in 2025. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cell And Gene Therapy Clinical Trial Services Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp

Browse Through More Reports Similar to the Global Cell And Gene Therapy Clinical Trial Services Market 2026, By The Business Research Company

Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

Cell And Gene Therapy Manufacturing Services Market 2026

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-market

Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Cell And Gene Therapy Clinical Trial Services Market?

The market size of clinical trial services for cell and gene therapy has seen a swift expansion in the past few years. The projections show that it would rise from $3.79 billion in 2024 to $4.18 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.4%. Factors contributing to growth during the historical period include a surge in chronic disease cases, higher demand for efficacious treatments for rare genetic conditions, increased governmental support for regenerative medicine research, a deeper understanding of the molecular mechanisms of various illnesses, and a heightened awareness about the promise of personalized medicine.

It is anticipated that the market for cell and gene therapy clinical trial services will experience robust growth in the coming years, reaching a monetary value of $6.02 billion in 2029, expanding at a CAGR of 9.5%. The predicted growth over the forecasted period can be credited to the rising global instances of genetic and auto-immune disorders, increasing funding from both public and private sectors towards gene therapy research, the proliferation of innovative technologies, and an uptick in genetic mismatches. Other key trends projected through the forecast period encompass the utilization of AI, machine learning, personalized medicine, technological breakthroughs, and gene therapies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

What Core Drivers Are Expected To Influence The Cell And Gene Therapy Clinical Trial Services Market?

An upsurge in genetic disease occurrences is projected to stimulate the expansion of the cell and gene therapy clinical trial services market. Genetic diseases, conditions triggered by alterations to an individual’s DNA or genetic makeup, are on the rise for several reasons, including the better accessibility of genetic testing, the emergence of genetic mutations, and the widespread practice of marrying within the family lineage. These clinical trial services for cell and gene therapy tackle the growth in genetic diseases by promoting the creation of new treatments, customizing treatments to fit each patient’s needs, hastening the process of transforming research outcomes into actual clinical use, and widening the treatment choices for patients afflicted with genetic conditions. For instance, as per the data provided by the Cystic Fibrosis (CF) Foundation, a non-profit organization based in the U.S., in July 2022, there has been a jump in the count of cystic fibrosis patients. In 2022, cystic fibrosis impacted nearly 40,000 children and grown-ups in the U.S., and a total of over 105,000 people across the globe have been identified with the condition. Hence, the escalating trend of genetic diseases is propelling the cell and gene therapy clinical trial services market’s growth.

What Are The Main Segment Classifications In The Cell And Gene Therapy Clinical Trial Services Market?

The cell and gene therapy clinical trial servicesmarket covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning; Supply And Logistic Services; Regulatory Affairs And Compliance; Data Management And Biostatics; Site Management And Monitoring; Other Services

2) By Therapy Type: Gene Therapy; Cell Therapy; Gene Modified Cell Therapy

3) By Indication: Oncology; Hematology; Metabolic Disorders; Infectious Diseases; Neurology; Cardiovascular Diseases; Musculoskeletal Disorders; Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes; Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development; Trial Feasibility Studies; Trial Design Consultation; Patient Recruitment And Enrollment Strategy; Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management; Cold Chain Logistics; Packaging And Labeling Services; Transportation And Distribution Of Biological Samples; Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting; Regulatory Submission And Documentation; Compliance With GMP (Good Manufacturing Practices); Regulatory Pathway Consultation; Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM); Statistical Analysis And Reporting; Clinical Data Monitoring; Data Integration And Validation; Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation; Clinical Monitoring And Site Visits; Patient Recruitment And Retention; Site Training And Support; Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement; Real-World Evidence (RWE) Studies; Post-Trial Services; Medical Writing And Documentation; Clinical Trial Auditing And Inspection

How Are Market Trends Influencing Competition In The Cell And Gene Therapy Clinical Trial Services Market?

Prominent businesses in the market for cell and gene therapy clinical trial services are increasingly investing in enhanced, customer relationship management system technology to boost efficiency levels and establish a competitive advantage within the market. The application of customer relationship management systems within cell and gene therapy clinical trial services can streamline the coordination and communication between trial participants, healthcare providers, and other stakeholders during the clinical trial process. To illustrate, in April 2023, AmerisourceBergen Corporation, a healthcare firm from the US, unveiled its Cell and Gene Therapy (CGT) Integration Hub. This platform, driven by their customer relationship management (CRM) system, is designed to enhance connectivity and smooth the processes across the cell and gene therapy treatment pathway. It aims to simplify care coordination by giving physicians and patient services teams improved oversight over therapy development and delivery, through features like quick benefits investigation, real-time status monitoring, and proactive alerts. The objective of CGT Integration Hub is to reduce obstacles and refine the overall experience of both patients and providers related to cell and gene therapies.

Which Companies Are Contributing Significantly To The Cell And Gene Therapy Clinical Trial Services Market Growth?

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Which Region Holds The Greatest Opportunity For Cell And Gene Therapy Clinical Trial Services Market Expansion?

North America was the largest region in the cell and gene therapy clinical trial services market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp

Browse Through More Reports Similar to the Global Cell And Gene Therapy Clinical Trial Services Market 2025, By The Business Research Company

Cell Therapy Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Surface Marker Detection Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-surface-marker-detection-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Cell And Gene Therapy Clinical Trial Services Market From 2025 To 2034?

The cell and gene therapy clinical trial services market size has experienced substantial growth in recent times. Projections indicate this market will expand from $3.79 billion in 2024 to reach $4.18 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 10.4%. Historically, this expansion has been driven by several factors, including the rising incidence of chronic diseases, a greater need for effective therapies for rare genetic disorders, enhanced government investment in regenerative medicine research, a deeper comprehension of the molecular mechanisms of various ailments, and a heightened recognition of personalized medicine’s promise.

The cell and gene therapy clinical trial services market size is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $6.02 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.5%. Factors contributing to this growth during the forecast period include the escalating global prevalence of genetic and auto-immune conditions, increased investment from both public and private sectors in gene therapy research, the expanding integration of new technologies, and an uptick in genetic defects. Key trends for the forecast period encompass the integration of AI, the utilization of machine learning, the implementation of personalized medicine, continuous technological advancements, and the development of new gene therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

What Are The Drivers Pushing New Developments In The Cell And Gene Therapy Clinical Trial Services Market?

The increasing prevalence of genetic conditions is anticipated to fuel expansion in the cell and gene therapy clinical trial services market in the future. These diseases stem from alterations in an individual’s DNA or genetic makeup. Several factors contribute to this rise, such as broader access to genetic screening, the emergence of genetic mutations, and the commonality of marriages between close relatives. To tackle the growing occurrence of genetic diseases, cell and gene therapy clinical trial services facilitate the creation of innovative treatments, customize therapies for specific patients, expedite the application of research into clinical settings, and broaden the therapeutic choices for those with genetic disorders. As an illustration, data from July 2022 by the Cystic Fibrosis (CF) Foundation, a US-based non-profit entity, indicated a notable increase in the population affected by cystic fibrosis. By 2022, nearly 40,000 children and adults in the United States were living with cystic fibrosis, with over 105,000 individuals diagnosed globally. Consequently, the escalating occurrence of genetic diseases is a key factor propelling the expansion of the cell and gene therapy clinical trial services market.

What Are The Major Segment Categories Driving The Cell And Gene Therapy Clinical Trial Services Market Growth?

The cell and gene therapy clinical trial servicesmarket covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning; Supply And Logistic Services; Regulatory Affairs And Compliance; Data Management And Biostatics; Site Management And Monitoring; Other Services

2) By Therapy Type: Gene Therapy; Cell Therapy; Gene Modified Cell Therapy

3) By Indication: Oncology; Hematology; Metabolic Disorders; Infectious Diseases; Neurology; Cardiovascular Diseases; Musculoskeletal Disorders; Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes; Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development; Trial Feasibility Studies; Trial Design Consultation; Patient Recruitment And Enrollment Strategy; Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management; Cold Chain Logistics; Packaging And Labeling Services; Transportation And Distribution Of Biological Samples; Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting; Regulatory Submission And Documentation; Compliance With GMP (Good Manufacturing Practices); Regulatory Pathway Consultation; Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM); Statistical Analysis And Reporting; Clinical Data Monitoring; Data Integration And Validation; Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation; Clinical Monitoring And Site Visits; Patient Recruitment And Retention; Site Training And Support; Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement; Real-World Evidence (RWE) Studies; Post-Trial Services; Medical Writing And Documentation; Clinical Trial Auditing And Inspection

How Are Trends Influencing The Cell And Gene Therapy Clinical Trial Services Market?

Leading companies in the cell and gene therapy clinical trial services market are dedicating resources to integrate advanced technology, particularly customer relationship management systems, to enhance efficiency and gain a competitive edge. The customer relationship management system employed by cell and gene therapy clinical trial services organizes and coordinates interactions with trial participants, healthcare providers, and other stakeholders throughout the entire clinical trial process. For example, in April 2023, AmerisourceBergen Corporation, a US-based healthcare company, introduced the Cell and Gene Therapy (CGT) Integration Hub, a platform designed to improve connectivity and streamline processes across the cell and gene therapy treatment pathway. This platform, supported by AmerisourceBergen’s customer relationship management (CRM) system, aims to simplify the path-to-care process, partly by offering physicians and patient services teams increased visibility across the therapy development and delivery. Featuring capabilities such as expedited benefits investigation, real-time status tracking, and proactive alerts, the CGT Integration Hub endeavors to simplify care coordination, reduce impediments, and enhance the overall experience for both patients and providers involved in delivering cell and gene therapies.

Which Industry Leaders Are Driving Innovation Across The Cell And Gene Therapy Clinical Trial Services Market?

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Which Geographies Are Emerging As Strong Markets For The Cell And Gene Therapy Clinical Trial Services Industry?

North America was the largest region in the cell and gene therapy clinical trial services market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Cell And Gene Therapy Clinical Trial Services Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp

Browse Through More Reports Similar to the Global Cell And Gene Therapy Clinical Trial Services Market 2025, By The Business Research Company

Cell Therapy Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Surface Marker Detection Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-surface-marker-detection-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What is the Anticipated CAGR of the Cell And Gene Therapy Clinical Trial Services Market, and What Factors Will Drive It?#_x000D_

In the past few years, the market size for cell and gene therapy clinical trial services has seen tremendous growth. It is expected to increase from $3.79 billion in 2024 to $4.18 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. Factors contributing to this significant growth during the historical period include growing prevalence of chronic ailments, heightened demand for effective cures for uncommon genetic diseases, amplified government funding directed towards research in regenerative medicine, expanded comprehension of molecular mechanisms contributing to various diseases, and heightened consciousness about the potential advantages of personalized medicine._x000D_

_x000D_

Strong expansion is predicted for the cell and gene therapy clinical trial services market in the approaching years, with projections estimating it to reach a value of $6.02 billion in 2029, expanding at a compound annual growth rate (CAGR) of 9.5%. The growth expected during the forecast period can be linked to a surge in global instances of genetic and auto-immune diseases, increased funding from public and private sectors for gene therapy research, rising uptake of cutting-edge technologies, and an escalation in the number of genetic flaws. Key trends for the upcoming period include the integration of AI, machine learning, personalized medicine, technological advancements, and gene therapies._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp_x000D_

_x000D_

#What External and Internal Drivers Are Contributing to the Growth of theCell And Gene Therapy Clinical Trial Services Market?#_x000D_

An increase in genetic diseases is set to boost the growth of the cell and gene therapy clinical trial services market in the coming period. Genetic ailments, caused by changes in an individual’s DNA or genetic makeup, are growing at a rapid pace for various reasons such as broader accessibility to genetic tests, the appearance of genetic mutations, and the widespread nature of consanguineous marriage. These clinical trial services for cell and gene therapy respond to the mounting prevalence of genetic diseases by promoting the creation of new treatments, personalizing treatments for each patient, quickening the application of research into clinical practice, and broadening the choices for those battling genetic disorders. For example, the Cystic Fibrosis (CF) Foundation, a non-profit organization based in the US, reported a surge in cystic fibrosis cases in July 2022. In the same year, nearly 40,000 children and adults in the US were affected by cystic fibrosis, and globally, over 105,000 individuals received a diagnosis. Thus, the surging rates of genetic diseases is fueling the growth of the cell and gene therapy clinical trial services market._x000D_

_x000D_

#What Segment Types Define the Cell And Gene Therapy Clinical Trial Services Market Structure?#_x000D_

The cell and gene therapy clinical trial servicesmarket covered in this report is segmented – _x000D_

_x000D_

1) By Service: Clinical Trial Design And Planning; Supply And Logistic Services; Regulatory Affairs And Compliance; Data Management And Biostatics; Site Management And Monitoring; Other Services_x000D_

2) By Therapy Type: Gene Therapy; Cell Therapy; Gene Modified Cell Therapy_x000D_

3) By Indication: Oncology; Hematology; Metabolic Disorders; Infectious Diseases; Neurology; Cardiovascular Diseases; Musculoskeletal Disorders; Other Indications_x000D_

4) By End-Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes; Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Clinical Trial Design And Planning: Protocol Development; Trial Feasibility Studies; Trial Design Consultation; Patient Recruitment And Enrollment Strategy; Risk-Based Monitoring Plans _x000D_

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management; Cold Chain Logistics; Packaging And Labeling Services; Transportation And Distribution Of Biological Samples; Customs And Import/Export Services _x000D_

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting; Regulatory Submission And Documentation; Compliance With GMP (Good Manufacturing Practices); Regulatory Pathway Consultation; Clinical Trial Applications (CTAs) _x000D_

4) By Data Management And Biostatistics: Clinical Data Management (CDM); Statistical Analysis And Reporting; Clinical Data Monitoring; Data Integration And Validation; Electronic Data Capture (EDC) Solutions _x000D_

5) By Site Management And Monitoring: Site Selection And Initiation; Clinical Monitoring And Site Visits; Patient Recruitment And Retention; Site Training And Support; Site Performance Monitoring _x000D_

6) By Other Services: Patient Advocacy And Engagement; Real-World Evidence (RWE) Studies; Post-Trial Services; Medical Writing And Documentation; Clinical Trial Auditing And Inspection_x000D_

_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Cell And Gene Therapy Clinical Trial Services Market?#_x000D_

North America was the largest region in the cell and gene therapy clinical trial services market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Long-Term Trends Are Transforming the Competitive Landscape of the Cell And Gene Therapy Clinical Trial Services Market?#_x000D_

Leading businesses in the cell and gene therapy clinical trial services sector are prioritizing the deployment of innovative technologies, including customer relationship management system technology, to elevate efficiency and secure a market advantage. The customer relationship management system used by these clinical trial services enables streamlining and harmonizing of communications with trial participants, healthcare providers, and other engaged parties throughout the clinical trial process. As an example, AmerisourceBergen Corporation, a healthcare firm from the US, unveiled the Cell and Gene Therapy (CGT) Integration Hub in April 2023. This platform, whose launch aimed at enhancing connectivity and simplifying processes all through the cell and gene therapy treatment pathway, is supported by AmerisourceBergen’s CRM system. It mainly makes strides towards smoothening the path-to-care process, partially by providing doctors and patient care teams with better visibility over the therapy development and delivery process. The CGT Integration Hub, equipped with features such as quick benefits investigation, real-time status monitoring, and early warning alerts, intends to facilitate care coordination, lessen obstacles, and enhance the overall experience for both patients and providers while offering cell and gene therapies._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report_x000D_

_x000D_

#What Is the Definition of the Cell And Gene Therapy Clinical Trial Services Market?#_x000D_

Cell and gene therapy clinical trial services refer to specialized services offered by contract research organizations (CROs) or clinical trial management corporations to facilitate the design, implementation, and management of clinical trials for cell and gene therapies. These services, which range from protocol design and patient recruiting to regulatory compliance and data administration, serve as the foundation for trials to progress smoothly, ensuring precision, efficacy, and adherence to high standards. _x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15535_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Cell And Gene Therapy Clinical Trial Services Market In 2029?

The market size for clinical trial services in cell and gene therapy has experienced swift growth in recent years. It is projected to expand from $3.79 billion in 2024 to reach $4.2 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 10.7%. The acceleration in growth during this historic period is linked to factors such as the higher frequency of chronic ailments, rising demand for efficient treatments for uncommon genetic maladies, enhanced governmental funding for regenerative medicine research, improved comprehension of molecular procedures related to various diseases, and growing awareness about the prospects of personalized medicine.

What Growth Rate Is Forecasted for the Cell And Gene Therapy Clinical Trial Services Market by 2029?

Over the next few years, rapid expansion is anticipated in the market for cell and gene therapy clinical trial services. With a compound annual growth rate (CAGR) of 10.3%, the market is projected to reach $6.22 billion by 2029. The rise in genetic and auto-immune disease cases worldwide, increased funding by the public and private sectors for gene therapy research, new technology utilization, and a surge in genetic defects are all contributing factors to the growth during this forecast period. Key trends expected in this period include the use of artificial intelligence, machine learning adoption, personalized medicine, technological advancements, and gene therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

Which Key Companies Are Shaping the Future of the Cell And Gene Therapy Clinical Trial Services Market?

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

Which Factors Are Driving Demand in the Cell And Gene Therapy Clinical Trial Services Industry?

The growth of the cell and gene therapy clinical trial services market is anticipated to be driven by the increasing prevalence of genetic disorders. These disorders stem from changes in an individual’s DNA or genetic make-up. Factors contributing to the surge in genetic disorders include the rise in genetic testing availability, genetic mutations occurrence, and the high rate of consanguineous marriages. This rising trend of genetic diseases is being tackled by the cell and gene therapy clinical trial services market by promoting innovative treatment development, personalizing treatments for each patient, hastening research conversion into clinical applications, and broadening the treatment prospects for patients with genetic conditions. For example, the Cystic Fibrosis (CF) Foundation, a not-for-profit organization based in the US, reported a substantial increase in the cystic fibrosis affected population in July 2022. In 2022, approximately 40,000 children and adults in the US were affected by cystic fibrosis, and globally, over 105,000 people were diagnosed. Hence, the escalating prevalence of genetic disorders is fuelling the cell and gene therapy clinical trial services market’s expansion.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp

How Is the Cell And Gene Therapy Clinical Trial Services Market Segmented by Several Divisions?

The cell and gene therapy clinical trial services market covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services

2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy

3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection

What are the Emerging Market Trends Driving the Growth of the Cell And Gene Therapy Clinical Trial Services Industry?

Leading corporations in the cell and gene therapy clinical trial services market are diversifying their strategies by implementing cutting-edge technology and customer relationship management system technology to enhance productivity and gain an upper hand in the competitive market. The customer relationship management system used by these services enhances the communication and interaction with trial participants, healthcare providers, and other involved parties during the clinical trial phase. For example, in April 2023, AmerisourceBergen Corporation, a healthcare firm based in the US, inaugurated the Cell and Gene Therapy (CGT) Integration Hub. This platform aims to augment connectivity and simplify processes throughout the cell and gene therapy treatment journey. Supported by AmerisourceBergen’s customer relationship management (CRM) system, it aims to streamline the care pathway by offering physicians and patient services teams increased transparency throughout therapy development and delivery. The CGT Integration Hub, equipped with features such as fast-tracked benefits investigation, real-time status updates, and preemptive alerts, is designed to simplify care coordination, reduce obstacles, and enhance the experience for patients and providers throughout the delivery of cell and gene therapies.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Which Regions Are Driving Growth in the Cell And Gene Therapy Clinical Trial Services Market?

North America was the largest region in the cell and gene therapy clinical trial services market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15535

This Report Delivers Insight On:

1. How big is the cell and gene therapy clinical trial services market, and how is it changing globally?

2. Who are the major companies in the cell and gene therapy clinical trial services market, and how are they performing?

3. What are the key opportunities and risks in the cell and gene therapy clinical trial services market right now?

4. Which products or customer segments are growing the most in the cell and gene therapy clinical trial services market?

5. What factors are helping or slowing down the growth of the cell and gene therapy clinical trial services market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model